1. WHO tuberculosis country profiles. http://www.who.int/tb/country/data/profiles/en/index.html (accessed 31 Jan 2013).
2. Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies;Dixon;Arthritis Rheum,2007
3. Dutch association of rheumatology, in collaboration with different medical associations. Dutch guideline: Controlled use of biologicals in immune mediated inflammatory disorders. 2011. http://www.nvalt.nl/service/richtlijnen (accessed 31 Jan 2013).
4. Tumour necrosis factor antagonists: structure, function, and tuberculosis risks;Wallis;Lancet Infect Dis,2008
5. Tuberculosis associated with blocking agents against tumor necrosis factor-alpha—California, 2002–2003;Centers for Disease Control and Prevention (CDC);MMWR Morb Mortal Wkly Rep,2004